[1]Ingle PV,Samsudin SZ,Chan PQ,et al.Development and novel therapeutics in hepatocellular carcinoma:A review[J].Ther Clin Risk Manag,2016,12(4):45-55.
[2]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
[3]Jiang P,Mizushima N.Autophagy and human diseases[J].Cell Res,2014,24(1):69-79.
[4]Indelicato M,Pucci B,Schito L,et al.Role of hypoxia and autophagy in MDA-MB-231 invasiveness[J].J Cell Physiol,2010,223(2):359-368.
[5]Li J,Yang B,Zhou Q,et al.Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition[J].Carcinogenesis,2013,34(6):1343-1351.
[6]Bhan A,Soleimani M,Mandal SS.Long noncoding RNA and cancer:A new paradigm[J].Cancer Res,2017,77(15):3965-3981.
[7]Schmitt AM,Chang HY.Long noncoding RNAs in cancer pathways[J].Cancer Cell,2016,29(4):452-463.
[8]He Y,Luo Y,Liang B,et al.Potential applications of MEG3 in cancer diagnosis and prognosis[J].Oncotarget,2017,8(42):73282-73295.
[9]Zhou Y,Zhang X,Klibanski A.MEG3 noncoding RNA:A tumor suppressor[J].J Mol Endocrinol,2012,48(3):R45-53.
[10]Ulitsky I,Bartel DP.lincRNAs:Genomics,evolution,and mechanisms[J].Cell,2013,154(1):26-46.
[11]Chan JJ,Tay Y.Noncoding RNA:RNA regulatory networks in cancer[J].Int J Mol Sci,2018,19(5):e1310.
[12]Yu WD,Wang H,He QF,et al.Long noncoding RNAs in cancer-immunity cycle[J].J Cell Physiol,2018,233:6518-6522.
[13]Hanly DJ,Esteller M,Berdasco M.Interplay between long non-coding RNAs and epigenetic machinery:Emerging targets in cancer[J]?Philos Trans R Soc Lond B Biol Sci,2018,373(1748):20170074.
[14]Levy JMM,Towers CG,Thorburn A.Targeting autophagy in cancer[J].Nat Rev Cancer,2017,17(9):528-542.
[15]Wen Jian,Wang Qian,Tu Wei.The role of autophagy in tumor treatment[J].Modern Oncology,2016,24(16):2633-2637.[温健,王倩,涂巍.自噬在肿瘤治疗中的作用[J].现代肿瘤医学,2016,24(16):2633-2637.]
[16]White E.The role for autophagy in cancer[J].J Clin Invest,2015,125(1):42-46.
[17]Sun T.Long noncoding RNAs act as regulators of autophagy in cancer[J].Pharmacol Res,2018,129(1):51-55.